The Cooper (LTS:0I3I) 5-Year EBITDA Growth Rate : 5.20% (As of Jan. 2024)

View and export this data going back to 2018. Start your Free Trial

What is The Cooper 5-Year EBITDA Growth Rate?

The Cooper's EBITDA per Share for the three months ended in Jan. 2024 was $1.23.

During the past 12 months, The Cooper's average EBITDA Per Share Growth Rate was -1.70% per year. During the past 3 years, the average EBITDA Per Share Growth Rate was 14.30% per year. During the past 5 years, the average EBITDA Per Share Growth Rate was 5.20% per year. During the past 10 years, the average EBITDA Per Share Growth Rate was 8.10% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

During the past 13 years, the highest 3-Year average EBITDA Per Share Growth Rate of The Cooper was 74.50% per year. The lowest was -156.50% per year. And the median was 13.30% per year.

Competitive Comparison of The Cooper's 5-Year EBITDA Growth Rate

For the Medical Instruments & Supplies subindustry, The Cooper's 5-Year EBITDA Growth Rate, along with its competitors' market caps and 5-Year EBITDA Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

The Cooper's 5-Year EBITDA Growth Rate Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, The Cooper's 5-Year EBITDA Growth Rate distribution charts can be found below:

* The bar in red indicates where The Cooper's 5-Year EBITDA Growth Rate falls into.

The Cooper 5-Year EBITDA Growth Rate Calculation

This is the 5-year average growth rate of EBITDA per Share. The growth rate is calculated with least square regression.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EBITDA per share growth rate.

The Cooper (LTS:0I3I) 5-Year EBITDA Growth Rate Explanation

EBITDA per Share is the amount of Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) per outstanding share of the company's stock.

Earnings Before Interest, Taxes, Depreciation, and Amortization (EBITDA) is what the company earns before it expenses interest, taxes, depreciation and amortization.

5-Year EBITDA Growth Rate gives an overview of the company's growth in operating profitability and is an important factor used in calculating Peter Lynch Fair Value.

The Cooper 5-Year EBITDA Growth Rate Related Terms

Thank you for viewing the detailed overview of The Cooper's 5-Year EBITDA Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.

The Cooper (LTS:0I3I) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » The Cooper Companies Inc (LTS:0I3I) » Definitions » 5-Year EBITDA Growth Rate

Comparable Companies

Traded in Other Exchanges

COO:USA COO:Mexico CP6:Germany C1OO34:Brazil

Address

6101 Bollinger Canyon Road, Suite 500, San Ramon, CA, USA, 94583

Website

https://www.coopercos.com

The Cooper Companies is one of the largest eye care companies in the U.S. It operates in two segments: CooperVision and CooperSurgical. CooperVision is a pure-play contact lens business and is composed of a suite of spherical, multifocal, and toric contact lenses. The company also has one of the most comprehensive specialty lens portfolios in the world. With brands including Proclear, Biofinity, MyDay, and clariti, Cooper controls roughly a quarter of the U.S. contact lens market. CooperSurgical, founded in 1990, is made up of equipment related to reproductive care, fertility, and women's care. Cooper has the broadest medical device coverage of the entire IVF cycle. It also has Paragard, the only hormone-free IUD in the U.S., and controls 17% of the U.S. IUD market.

The Cooper (LTS:0I3I) Headlines

No Headlines